Bluejay Diagnostics, Inc.
NASDAQ Capital MarketTotal Valuation
Bluejay Diagnostics, Inc. carries a market capitalization of 861,296.00, placing it among publicly traded companies globally. Its enterprise value stands at -8.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 861,296.00 |
| Enterprise Value | -8.28M |
Share Statistics
Bluejay Diagnostics, Inc. currently has 1.03M shares outstanding.
| Shares Outstanding | 1.03M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.13 |
| P/TBV Ratio | 0.13 |
| P/FCF Ratio | -0.25 |
| P/OCF Ratio | -0.23 |
Financial Position
Bluejay Diagnostics, Inc. maintains a current ratio of 4.64, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.78, indicating moderate leverage, while an interest coverage ratio of -18,569.15 demonstrates limited ability to service its debt obligations.
| Current Ratio | 4.64 |
| Quick Ratio | 4.53 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -18,569.15 |
Financial Efficiency
| Return on Equity (ROE) | -98.89 |
| Return on Assets (ROA) | -81.07 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Bluejay Diagnostics, Inc.'s stock has declined approximately -85.34507% over the past 52 weeks. The 50-day moving average sits at 1.12, while the 200-day moving average is 2.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.34507% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 2.45 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -7.19M, while operating income came in at -7.37M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -7.37M |
| Pretax Income | -7.27M |
| Net Income | -7.27M |
| EBITDA | -7.19M |
| EBIT | -7.37M |
| Earnings Per Share (EPS) | -6.31 |
Balance Sheet
Bluejay Diagnostics, Inc. holds 9.60M in cash and equivalents against 73,444.00 in total debt, resulting in a net debt position of -9.60M. Total book value stands at 9.41M, with working capital of 7.70M providing operational flexibility.
| Cash & Cash Equivalents | 9.60M |
| Total Debt | 73,444.00 |
| Net Debt | -9.60M |
| Equity (Book Value) | 9.41M |
| Book Value Per Share | 9.10 |
| Working Capital | 7.70M |
Cash Flow
Bluejay Diagnostics, Inc. produced -5.90M in operating cash flow over the past twelve months. After subtracting -335,497.00 in capital expenditures, free cash flow totaled -6.24M - equivalent to -5.41 per share.
| Operating Cash Flow | -5.90M |
| Capital Expenditures | -335,497.00 |
| Free Cash Flow | -6.24M |
| FCF Per Share | -5.41 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -917.39 |
| FCF Yield | -402.58 |
Stock Splits
Bluejay Diagnostics, Inc.'s most recent stock split took place on January 29, 2026 with a 4:1 split ratio.
| Last Split Date | 1/29/2026 |
| Split Ratio | 4:1 |
Scores
Bluejay Diagnostics, Inc. posts an Altman Z-Score of -6.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.51 |